Episode 67
Biotech Hangout
00:00
The Challenges of Big Pharma's Dance With the Technologies of the Future
Timothy Stanley: One of the things that I thought immediately when I saw this, something that we've been talking a lot about lately is big pharma's dance with like the technologies of the future. We talked about this last week when Pfizer and flagship got to together, how it kind of gives Pfizer an opportunity to maybe, you know, dabble a little bit in some of those technologies. And so I just think it's interesting that the history of these things seems to be that the early stage development doesn't seem to go so well in the big pharma house. He says if companies can structure themselves in a way where they can sustain that commitment, it can be very
Transcript
Play full episode
